Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Anticoccidial Drugs Market

Anticoccidial Drugs Market Trends

Report ID: GMI9889
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Anticoccidial Drugs Market Trends

The global livestock population is expanding to meet the rising demand for animal products. As the number of livestock animals increases, so does the need for effective disease management practices to ensure their health and productivity
.
The higher concentration of animals in farming operations increases the risk of disease transmission, including coccidiosis, making the use of anticoccidial drugs essential. This growing livestock population requires robust and efficient disease prevention measures, thereby boosting the demand for anticoccidial drugs.
As farming practices become more intensive and livestock densities increases, the prevalence and spread of coccidiosis is also escalating.
Additionally, the high cost associated with coccidiosis outbreaks necessitates effective prevention and treatment strategies, thereby driving the demand for anticoccidial drugs to maintain livestock health and productivity.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global anticoccidial drugs market size was valued at USD 183.1 million in 2023 and is anticipated to grow at 4.1% CAGR during 2024-2032, driven by the increasing demand for poultry products, such as meat and eggs, due to the growing demand for protein-rich diets.

The synthetic compounds segment of the anticoccidial drugs industry held 62.1% share in 2023 and will expand rapidly through 2032, due to its high efficacy and broad spectrum of activity against various coccidia species.

North America anticoccidial drugs market is projected to witness 3.9% CAGR during 2024-2032, owing to substantial livestock and poultry industry, where coccidiosis is a prevalent concern.

Elanco Animal Health Incorporated, Huvepharma EOOD, Impextraco NV, Merck & Co., Inc, Phibro Animal Health Corporation, Vetoquinol SA, Virbac SA, and Zoetis Inc. among others.